Ascend Wellness Holdings (AAWH) Free Cash Flow (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Free Cash Flow of -$24.6 million in Q1 2026, down 361.0% quarter-over-quarter from $9.4 million in Q4 2025, and down 1335.11% on a YoY basis from $2.0 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Free Cash Flow (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$24.6 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 1335.11% year-over-year to -$24.6 million; the TTM figure through Mar 2026 stood at -$14.5 million (down 127.3% YoY), while the FY2025 annual figure was $12.0 million, down 76.27% from the prior year.
- Free Cash Flow was -$24.6 million for Q1 2026 at Ascend Wellness Holdings, down from $9.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $26.5 million in Q3 2023 to a low of -$24.6 million in Q1 2026.
- Historically, Free Cash Flow has averaged $2.6 million across 5 years, with a median of $1.8 million in 2023.
- The sharpest annual moves came in 2023 and 2026: Free Cash Flow surged 9362.94% in 2023, then plunged 1335.11% in 2026.
- A 5-year view of Free Cash Flow shows it stood at -$15.5 million in 2022, then jumped by 90.48% to -$1.5 million in 2023, then surged by 1156.36% to $15.6 million in 2024, then slumped by 39.65% to $9.4 million in 2025, then tumbled by 361.0% to -$24.6 million in 2026.
- The last three Free Cash Flow figures came in at -$24.6 million (Q1 2026), $9.4 million (Q4 2025), and -$18.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 136.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 123.09 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 46.40 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -24.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.59 Mn |
| Mar 31, 2026 | -24.59 Mn |
| Dec 31, 2025 | 9.42 Mn |
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | -18.06 Mn |
| Sep 30, 2025 | -18.06 Mn |
| Jun 30, 2025 | 18.69 Mn |
| Jun 30, 2025 | 18.69 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 15.61 Mn |
| Dec 31, 2024 | 15.61 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | 24.13 Mn |
| Jun 30, 2024 | 24.13 Mn |
| Mar 31, 2024 | -509,000.00 |
| Mar 31, 2024 | -509,000.00 |
| Dec 31, 2023 | -1.48 Mn |
| Dec 31, 2023 | -1.48 Mn |